Aliquots - Research Briefs
-
May 9, 2018
Putting the brakes on sepsis
An enzyme called PTEN reduces inflammatory signaling and mortality in sepsis, suggesting it may be a good therapeutic target for this life-threatening complication of infection. -
May 7, 2018
Records point to drug-drug interaction
Patients who take a cholesterol-lowering statin drug while taking the antibiotic daptomycin have increased risk of developing muscle weakness or a more severe form of muscle damage. -
May 4, 2018
New breast cancer targets
A special genetic analysis has revealed candidate genes associated with increased risk of breast cancer. -
May 3, 2018
Understanding HDL structure
Structural features of newly formed HDL particles will help guide understanding of “good cholesterol” and its function. -
April 23, 2018
Toxin floats on lipid rafts
The bacterium H. pylori is a leading cause of stomach cancer, and Vanderbilt researchers are studying how one of its toxins gets into cells. -
April 20, 2018
Disease-fighting antibody production
New research links nutrient-responsive cellular signaling to the antibody-mediated immune response. -
April 19, 2018
How the skin protects
Treatments for common skin conditions such as atopic dermatitis may be improved by understanding the enzymes responsible for forming the skin’s water-tight barrier.